{{Rsnum
|rsid=2071002
|Gene=NQO2
|Chromosome=6
|position=3000069
|Orientation=plus
|GMAF=0.3182
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=NQO2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 50.9 | 40.2 | 8.9
| HCB | 45.2 | 43.0 | 11.9
| JPT | 45.1 | 39.8 | 15.0
| YRI | 34.0 | 53.7 | 12.2
| ASW | 36.8 | 50.9 | 12.3
| CHB | 45.2 | 43.0 | 11.9
| CHD | 28.4 | 61.5 | 10.1
| GIH | 66.3 | 28.7 | 5.0
| LWK | 35.5 | 49.1 | 15.5
| MEX | 37.9 | 60.3 | 1.7
| MKK | 32.1 | 55.8 | 12.2
| TSI | 58.8 | 35.3 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19351655
|Title=Functional Polymorphisms, Altered Gene Expression and Genetic Association Link NRH:Quinone Oxidoreductase 2 to Breast Cancer with Wild-type p53.
}}

{{omim
|desc=NAD(P)H DEHYDROGENASE, QUINONE 2; NQO2
|id=160998
|rsnum=2071002
}}

{{omim
|id=114480
|rsnum=2071002
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}